ascendis pharma glp-1 receptor agonists weight management diabetes treatments GLP1 Agonists—Effects beyond Obesity and Advances in GLP-1 receptor agonists

This helps minimize any potential digestive adjustments

Growth factor independence in vitro of primary melanoma cells from advanced but not early or intermediate lesions

Studi di teratogenesi hanno dimostrato che la L-Carnitina non determina effetti nocivi sulla gestante, sulla gestazione e sullo sviluppo embrio-fetale

"A review of Acceptance and Commitment Therapy (ACT) empirical evidence: Correlational, experimental psychopathology, component and outcome studies"

The GLP-1RA liraglutide has also been approved for the treatment of obesity at a higher standard dose (3 mg once daily) compared to the standard dose used for T2D treatment (1.2 mg once daily) due to the results of the SCALE study program (37, 38)